title: In Vivo Fluorescent Labeling of Tumor Cells with the HaloTag® Technology.
abstract: Many fluorescent sensors are currently available for in vitro bio-physiological microscopic imaging. The ability to label cells in living animals with these fluorescent sensors would help translate some of these assays into in vivo applications. To achieve this goal, the first step is to establish a method for selectively labeling target cells with exogenous fluorophores. Here we tested whether the HaloTag® protein tagging system provides specific labeling of xenograft tumors in living animals. After systemic delivery of fluorophore-conjugated ligands, we performed whole animal planar fluorescent imaging to determine uptake in tag-expressing HCT116 xenografts. Our results demonstrate that HaloTag ligands containing red or near-infrared fluorophores have enhanced tumor uptake and are suitable for non-invasive in vivo imaging. Our proof-of-concept results establish feasibility for using HaloTag technology for bio-physiological imaging in living animals.
authors.affiliation: Lurie Family Imaging Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: Jen-Chieh
authors.initials: JC
authors.lastname: Tseng
authors.forename: Hélène A
authors.initials: HA
authors.lastname: Benink
authors.forename: Mark G
authors.initials: MG
authors.lastname: McDougall
authors.forename: Isabel
authors.initials: I
authors.lastname: Chico-Calero
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Kung
keywords: Fluorescent imaging; HaloTag; in vivo labeling.; tumor xenograft